RNA for treatment of autoimmune diseases

US11701413B2 · kind B2 · utility

Assignees

• BIONTECH SE · DE
• TRON—Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz · DE

Inventors

• Ugur Sahin · Mainz, DE
• Sebastian Kreiter · Mainz, DE
• Christina Krienke · Dienheim, DE
• Jutta Petschenka · Mainz, DE
• Lena Mareen Kranz · Mainz, DE
• Mustafa Diken · Mainz, DE

Key dates

• Filing date: Apr 10, 2018
• Grant date: Jul 18, 2023
• Expiry date: Mar 3, 2039

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2310/335
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to non-immunogenic RNA. This RNA forms the basis for the development of therapeutic agents for inducing tolerance towards an autoantigen and thus, for the treatment of autoimmune diseases.